Literature DB >> 16880738

Addressing the role of cell adhesion in tumor cell dormancy.

Donald E White1, Jonathan H Rayment, William J Muller.   

Abstract

The dissemination of tumor cells prior to the surgical resection of early stage tumors poses a serious risk to the disease free survival of cancer patients. This risk arises from the latent capacity of these cells to form solid metastatic lesions after a prolonged period of dormancy, exacerbated by the fact that these cells are often refractory to adjuvant chemotherapeutic protocols. Ensuring the long term survival of cancer patients therefore necessitates an understanding of the mechanisms of tumor cell dormancy and the accompanying drug resistance. Experiments designed to compare the biological behavior of metastatic versus nonmetastatic variants of tumor cells provide evidence that there exists a phenomenon of single-cell dormancy which may depend on a reciprocal dialogue between the tumor cell and the tissue microenvironment. Through a combination of 3-dimensional cell culture technique and in vivo models investigators are now beginning to elucidate the molecular mechanisms underlying this phenomenon. Here we review the results of a series of experiments describing the role of cell adhesion events in dictating tumor cell behavior, including the balance between proliferation and dormancy, and the acquisition of drug resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880738     DOI: 10.4161/cc.5.16.2993

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  18 in total

Review 1.  Environment-mediated drug resistance: a major contributor to minimal residual disease.

Authors:  Mark B Meads; Robert A Gatenby; William S Dalton
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

2.  E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.

Authors:  Hyung-Gyoo Kang; Jasmine M Jenabi; Jingsong Zhang; Nino Keshelava; Hiroyuki Shimada; William A May; Tony Ng; C Patrick Reynolds; Timothy J Triche; Poul H B Sorensen
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

Review 3.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

4.  The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities.

Authors:  Julio A Aguirre-Ghiso
Journal:  Cell Cycle       Date:  2006-08-15       Impact factor: 4.534

Review 5.  Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.

Authors:  Dalit Barkan; Jeffrey E Green; Ann F Chambers
Journal:  Eur J Cancer       Date:  2010-03-19       Impact factor: 9.162

6.  Overexpression of cell surface cytokeratin 8 in multidrug-resistant MCF-7/MX cells enhances cell adhesion to the extracellular matrix.

Authors:  Fang Liu; Zhong Chen; Jinhong Wang; Xiaofeng Shao; Ziyou Cui; Chunzheng Yang; Zhenping Zhu; Dongsheng Xiong
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

Review 7.  Dormancy in breast cancer.

Authors:  Malgorzata Banys; Andreas D Hartkopf; Natalia Krawczyk; Tatjana Kaiser; Franziska Meier-Stiegen; Tanja Fehm; Hans Neubauer
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-12-05

8.  Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression.

Authors:  Junko Yoshida; Akiko Horiuchi; Norihiko Kikuchi; Akiko Hayashi; Ryosuke Osada; Satoshi Ohira; Tanri Shiozawa; Ikuo Konishi
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

Review 9.  Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies.

Authors:  M Mimeault; R Hauke; S K Batra
Journal:  Clin Pharmacol Ther       Date:  2007-09-05       Impact factor: 6.875

10.  Cancer microenvironment and cancer vaccine.

Authors:  Zhen-Yu Ding; Xue-Lin Zou; Yu-Quan Wei
Journal:  Cancer Microenviron       Date:  2012-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.